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Abstract
Background: It has been well established that breastfeeding is beneficial for child health, however there has been
debate regarding the effect of lactation on maternal health in the presence of HIV infection and the need for
nutritional supplementation in HIV positive lactating mothers.
Aims: To assess the effect of nutritional supplementation to HIV infected lactating mothers on nutritional and
health status of mothers and their infants.
Methods: A randomized controlled clinical trial to study the impact of nutritional supplementation on
breastfeeding mothers. Measurements included anthropometry; body composition indicators; CD4 count,
haemoglobin and albumin; as well as incidence rates of opportunistic infections; depression and quality of life
scores. Infant measurements included anthropometry, development and rates of infections.
Results: The supplement made no significant impact on any maternal or infant outcomes. However in the small
group of mothers with low BMI, the intake of supplement was significantly associated with preventing loss of lean
body mass (1.32 kg vs. 3.17 kg; p = 0.026). There was no significant impact of supplementation on the infants.
Conclusions: A 50 g daily nutritional supplement to breastfeeding mothers had no or limited effect on mother
and child health outcomes.
Clinical trial registration: ISRCTN68128332 (http://www.controlled-trials.com/ISRCTN68128332)
Keywords: HIV positive mothers, HIV exposed infants, breastfeeding, nutrition supplement, body composition,
anthropometry, SRQ 20, RCT
Background
Breastfeeding is the optimal source of nutrition for all
infants [1,2]. Although breastfeeding is associated with a
risk of post-natal vertical transmission of HIV; it has
been well established that in resource-poor commu-
nities, there are serious repercussions of not breastfeed-
ing or even of a short duration breastfeeding on HIV
free survival of the infants [3-8]. Studies have shown
that effective antiretroviral prophylaxis to the mother or
infant during breastfeeding can reduce vertical
transmission to as low as 1% [7,9-12]. WHO therefore
revised its PMTCT (prevention of mother to child trans-
mission) guidelines in 2010 to help maximize HIV free
survival of infants by recommending longer breastfeed-
ing with prophylaxis as well as the timely start of antire-
troviral therapy (ART) in the mothers [13].
Women in resource-constrained settings such as sub-
Saharan Africa are carrying a double burden of HIV and
food insecurity and are therefore prone to nutritional
deficiencies [14-17].
Nutrition and immunity have a synergistic relationship
and deficiencies in either can have serious health impli-
cations [18,19]. Apart from food shortages, HIV infec-
tion is also frequently associated with malnutrition due
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ments due to increased metabolism; and decreased
absorption due to opportunistic infections [20]. Besides
this, the resting energy expenditure in HIV infected
women has been shown to be higher than that in their
HIV uninfected counterpart [21]. There was therefore
some concern raised regarding the effect of breastfeed-
ing on maternal health [22]. However, it was shown by
Papathakis et al. that although HIV positive lactating
mothers lost more weight and subcutaneous fat than the
HIV negative women, there was no significant difference
in their change in lean body mass [23]. Two longitudinal
studies of assessments of maternal morbidity and mor-
tality also showed that breastfeeding did not add an
additional burden on the health of HIV positive mothers
[24,25].
It has been estimated, based on a mean milk produc-
tion of 699-854 g/day, that exclusively breastfeeding
mothers require an increased energy intake of 614-750
kcal/day [26]. The energy conversion from food intake
and body stores to milk energy has been shown to be
very efficient at 80% [26]. Lactating women in most
societies tend to have a normal to lower total energy
expenditure in comparison to the non-lactating women
as they are mostly sedentary; however in certain socie-
ties, mothers have to return to work in order to sustain
a living especially to labour-intensive work. Well-nour-
ished women tend to lose more weight (0.8 kg/month)
during lactation in comparison to the under-nourished
women (0.1 kg/month) possibly due to conservation of
energy [26]. This rate of weight loss in the well-nour-
ished women corresponds to a mobilization of energy
from their stores at a rate of 170 kcal/day [26]; however
it is estimated that they would still require an additional
505 kcal/day during breastfeeding; and undernourished
mothers who already have low reserves need to compen-
sate by increasing their daily energy consumption by 675
kcal/day [26]. Women in our clinic community are very
food insecure due to unemployment and mostly rely on
child support grants. The few who are employed usually
work as domestic workers this being a peri-urban area.
This obviously leads to the question ‘would giving food
or a well-balanced food supplement help to circumvent
the energy cost of lactation?’
S i n c et od a t et h e r ea r en op u b l i s h e ds t u d i e so nt h e
impact of nutritional supplements on HIV positive lac-
tating mothers we tested the effect of a food supplement
in the form of a peanut/soya milk based spread enriched
with micronutrients(Table 1). The supplement, “Sibusiso
ready food supplement” was also being used by the
national department of health (DOH) as a therapeutic
supplement in malnutrition and HIV associated wasting;
and was therefore presumed to be acceptable in taste
and texture to our community. Since loss in lean body
mass (LBM) is a prognostic marker in HIV infection
[27] and changes in body composition are more sensi-
tive in testing interventions [28] we used change in
LBM rather than anthropometric measurements alone
to assess the effect of the supplement. Karnofsky score,
a performance score used globally as an indicator of
health and well-being and recommended for use in
adults with HIV infection by WHO was also used as an
indicator of health [29].
Food security is one of the main issues, which affect
the day to day living in the impoverished household,
and alleviation of such a stressor through nutritive inter-
vention may also impact positively on the mother’s
emotional disposition. We therefore monitored the
mother’s mental health status using the WHO self-
reporting questionnaire (SRQ20), which has been vali-
dated in our population [30,31]. The mother’sm e n t a l
health status may positively affect the level of care she
gives to her baby, thereby improving the baby’sg r o w t h
Table 1 Composition of Sibusiso ready food supplement
Nutrients Per 50 g serving %RDA per 50 g
Energy (kj) 1176
Protein (g) 8
Carbohydrate (g) 24
Fat (g) 17.5
Fiber (g) 0.95
Vitamin A (mcg RE) 600 75
Vitamin D (mcg) 58 3
Vitamin E (mg) 15 100
Vitamin K (mcg) 25
Vitamin C (mg) 75 100
Vitamin B1 (mg) 1.1 79
Vitamin B2 (mg) 1.1 69
Vitamin B3 (mg) 10 56
Vitamin B6 (mg) 1.3 50
Folic acid (mcg) 300 75
Vitamin B12 (mcg) 1.8 60
Biotin (mcg) 30 100
Pantothenic acid (mg) 48 0
Calcium (mg) 1000 91
Phosphorus (mg) 700 80
Iron (mg) 14 100
Magnesium (mg) 80 23
Zinc (mg) 53 3
Iodine (mcg) 150 100
Selenium (mcg) 55 100
Sodium (mg) < 290
Potassium (mg) 595
Copper (mcg) 700
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effect of the supplement on growth and development of
the infant as well as incidence of opportunistic infec-
tions like diarrhoea and lower respiratory tract infec-
tions (LRTI). As all women in the study received a
multivitamin supplement (national PMTCT guidelines)
we were not in a position to test the impact of micronu-
trients on health and nutritional status independently
but instead tested the impact of providing a food sup-
plement in conjunction with the multivitamin on the
nutritional status of the breastfeeding mothers as well as
on the incidence of opportunistic infections and their
disease progression.
Methods
Study population and design
The study sample consisted of HIV positive pregnant
women of Zulu ethnicity attending the antenatal clinic
(ANC) at Umkhumbane Community Health centre at
Cato Manor. Breastfeeding mothers were randomized in
a controlled clinical trial (RCT) to receive supplementa-
tion or non-nutritive household supplies. The supple-
ment was a peanut/soya milk spread enriched with
micronutrients and came packaged in plastic tubs. A
daily serving of 50 g of the nutrition supplement pro-
vided 280 kcal energy and 8 g protein. The non-nutri-
tive supplies included tea; shampoo and conditioner of
equal monetary value and were therefore not considered
to have an impact on nutrition. Randomisation took
place by mothers removing a card pre-marked with
group number from a slit in a closed box; this was
done to enable them to be confident that the randomi-
sation was unbiased. Randomisation was conducted by a
study counsellor who maintained a separate record of
the randomisation log. Outcomes were assessed by a
separate clinician. To ensure that the clinician was
blinded, the counsellors issued a brown bag containing
either the nutritional supplement or the non-nutritive
supplies. Both supplement and the non-nutritive sup-
plies were packed in identical brown bags in an attempt
to mask the allocation of group. The data on the rando-
mization was collected using subject identification num-
bers only so as to reduce observer bias. To prevent
dilution of the effect of the intervention and mothers
discussing the content of their brown bags, separate
clinic visit days were allocated for the two groups. To
monitor adherence, a monthly register with mothers’
signatures was maintained as well as a questionnaire
was administeredto the mothers at every visit discussing
daily intake of the supplement and any possible reasons
for not taking the supplement including information on
any benefits or side-effects that they attributed to the
supplement. The counselors also tried to ascertain that
the mothers were not sharing the supplement with
members of their household by interviewing the
mothers.
Sample size calculations
The study was designed to detect a difference of ≥ 4k g
between the two groups. It was determined that a sam-
p l es i z eo f4 0i ne a c hg r o u pw o u l da c h i e v e9 0 %p o w e r
using a one-sided, two-sample t-test. The true difference
between the means was assumed to be 0.00. The signifi-
cance level (alpha) of the test was 0.025. The data are
drawn from populations with mean weights with stan-
dard deviations of 6.70 and 3.60 kg obtained from pilot-
ing the body composition methods in the same
population.
Allowing for a 30% loss to follow-up due to high
mobility of the population post delivery, we estimated a
sample size of 52 in each group. Then adding an addi-
tional 30% for loss of datadue to missed visits for body
composition analyses or laboratory tests; we estimated a
sample sizeof 64 in each group.
Enrollment and exclusion criteria
HIV positive mothers attending the ANC were referred
to the on-site MTCT Plus programme, an internation-
ally funded programme that provided PMTCT services
as well as comprehensive care and treatment for HIV
infected mothers and their families. Mothers were routi-
nely counselled on the feeding options and risks thereof
were explained. Breastfeeding HIV positive mothers
were referred to dedicated study counsellors who were
housed in an independent building a few metres from
the clinic. These study counsellors screened the mothers
for study eligibility and counselled them on the study
procedures. Only mothers planning to breastfeed for at
least 6 months were eligible to enter the study. Mothers
with advanced disease (CD4 < 200 or WHO stage 3 and
4) requiring ART and those not resident in the area
were not eligible for recruitment. In addition, mothers
of infants requiring specialized management and with
gestation less than 36 weeks were not eligible for study
enrolment. Interested mothers were pre-enrolled after a
written informed consent was obtained at the next
antenatal visit. Mothers were then seen at 2 weeks post-
delivery and officially enrolled into the study.
Study procedures and visits
Study assessments for both mothers and their infants
were done at 2 and 6 weeks post-delivery and monthly
thereafter till 6 months of age with a final study visit at
9 months. At each visit, a clinical examination and
anthropometric measurements were done; along with a
developmental assessment on the infants and Karnofsky
scoring on the mothers. Body composition and SRQ 20
assessments were done on the mother at 2 weeks and
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tive infants were assessed for any signs of disease pro-
gression; opportunistic infections; WHO disease staging;
and CD4 counts. When indicated they were started on
ART as per national guidelines [34].
A 24-hour dietary recall was done at 3, 6 and 9
months to assess for similarity of dietary intake in the
groups to rule out any confounding for the outcome of
supplementation. Infant feeding history was taken at
each visit.
Infants received multivitamins and cotrimoxazole for
Pneumocystis jiroveci pneumonia (PCP) prophylaxis
from 6 weeks that was discontinued when the infant
was confirmed HIV DNA PCR negative. Mothers
received PCP prophylaxis if indicated.
Anthropometric measurements included weight;
height; length; mid-upper arm circumference (MUAC);
and triceps skinfold thickness (TSF) on both mother and
infant. In addition head circumference measurements
w e r et a k e no nt h ei n f a n t s .A l lm e a s u r e m e n t sw e r ep e r -
formed in duplicate as per ISAK (International Society
for the Advancement of Kinanthropometry) methods by
either the principal investigator or the dietitian to reduce
inter-observer variability and enhance reliability [35].
Body Mass Index (BMI) was calculated by dividing the
weight of the subject by their height squared (kg/m
2).
All women in the study were counseled and supported
to practice exclusive breastfeeding for 6 months.
Mothers whose infants were asymptomatic and who
tested HIV negative at 6 weeks were counseled on either
discontinuing breastfeeding at 6 months, or heat-treat-
ing expressed breast milk [36,37].
Body composition
Saliva samples from mothers were collected to measure
Deuterium enrichment using standardized IAEA (Inter-
national Atomic Energy Agency) methodology [38].
These samples were analysed for total body water
(TBW) using an FTIR (Fourier transform infra-red spec-
trophotometer). LBM was calculated from the TBW
(73.2% of TBW). Fat mass (FM) was calculated as the
difference between the body weight and the LBM.
Laboratory methodology
Maternal bloods were done at 2 weeks and at 6 months
and tests included haemoglobin; haematocrit; mean cell
volume; platelet count; white cell count and lymphocyte
count; total protein and albumin; and CD4 counts.
Infants had a HIV DNA PCR done routinely at 6 weeks
and the infants who tested positive had a repeat PCR at
10 weeks. A DNA PCR was repeated at 9 months in
infants who tested negative at 6 weeks. All investigations
were routine tests done at the accredited National
Health Laboratory Services.
Data preparation
Data was entered into an MS Access database (
©MS
Office 2003). It was rechecked for any missing informa-
tion and entry errors. A unique subject identification
number to maintain confidentiality identified mothers
and infants.
To study associations/trends within categories: BMI
was categorized as ≤ 24.9 kg/m
2 and ≥ 25 kg/m
2.D i s -
ease progression was categorized as progression to
WHO stage 3 or higher; a poor Karnofsky score was
categorized as 80% or below (80% and above is asso-
ciated with ability to do normal activity); and the WHO
cutoff of an SRQ20 score of 8 and above (associated
with depression) was used as an indicator of depression
[30,31].
Statistical methods
SPSS 15.0 for windows was used for analysis (
© SPSS
Inc.). The two groups were compared for baseline socio-
economic as well as clinical criteria to assess for
similarity.
Continuous variables were checked for normality of
distribution. Independent t tests and chi-squared tests
were done for the continuous and categorical variables
respectively. Non-parametric tests were conducted for
the skewed continuous variables and medians with their
inter-quartile range are reported.
Paired T tests for normally distributed variables and
Wilcoxon signed rank test for skewed variables were
performed to study changes over time in the laboratory
parameters, anthropometric and body composition
measurements.
Incidence rates and incidence rate ratios (IRR) were
calculated for clinical events, opportunistic infections,
Karnofsky score and SRQ 20 score using STATA 9.2
(
©StataCorp).
As low BMI is considered to be an important prog-
nostic marker for breastfeeding HIV positive women, all
anthropometric, body composition, laboratory and dis-
ease progression parameters were analysed according to
BMI category. As BMI ≥ 25 kg/m
2 was being used by
the province as a cutoff for not being eligible for supple-
ments in the HIV positive population and as our median
BMI was 26 kg/m
2, we categorized the BMI in our sam-
p l eu s i n gt h es a m ec a t e g o r i z a t i o na st h ep r o v i n c e :≥ 25
kg/m
2 and < 25 kg/m
2. An intention to treat analysis
was conducted using generalized estimating equations
(GEE) with robust estimators and an exchangeable cov-
ariance matrix to analyse the continuous variables over
time controlling for socio-economic status; baseline
CD4 and BMI. Generalised linear models (GLM) with
Poisson distribution and log function were used to ana-
lyse the incidence rates of the opportunistic infections.
The WHO igrowup tool using the 2007 WHO growth
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[39].
Ethical considerations
Ethical approval for the study was obtained from the
Bioethics Committee of the University of KwaZulu-
Natal (H081/05).
Results
Between December 2006 to July 2008; 129 mothers were
eligible for analysis as they fulfilled the eligibility criteria
namely completing at least 2 study visits; 63 in the con-
trol group and 66 in the supplemented group (Figure 1).
Study follow-up was complete by May 2009. There were
no statistically significant differences between the two
groups of mothers or infants at baseline (Table 2 and 3).
All mothers were WHO stage 1 in the two groups
except for one mother in the supplemented group who
was WHO stage 2. There were no statistically significant
differences between the infants at baseline.
Unexpectedly, not all the mothers breastfed for the
full 6 months. Mothers in the control group breastfed
their infants longer than the supplemented group; med-
ian duration 6 months (range 1- 9) vs. 5.5 months
(range 1-7); p = 0.009. Therefore, duration of breastfeed-
ing was included as a confounder when assessing infant
growth; and other maternal and infant variables. Exclu-
sive breastfeeding rates were 58.6% at 6 months.
Amongst the reasons for stopping breastfeeding before 6
months, returning to work was the most frequent
(12.4%). Since the hypothesis was that the supplement
was given to improve nutritional status of lactating
mothers, when mothers came to their monthly visits, if
they had stopped breastfeeding prior to the visit, the
supplement was no longer issued. The median intake of
supplement was 5.5 months (Interquartile range (IQR)
2.94- 6). While monitoring adherence, 33.3% of the
mothers revealed that they did not consume the daily
amount of supplement strictly according to protocol
and there were occasional days when they did not use
the supplement. The most common reason given was
that the paste was very sweet (39.4%). When we ana-
lysed the dietary intake as assessed by 24-hour recall we
found no significant differences in the dietary intakes in
the two groups. The median energy intake at 3 months
was 2090 kcal/day in the control group and 1972 kcal/
day; however there was no significant difference between
the two groups.
On assessing anthropometric and body composition
measurements, no significant differences were seen
between the two groups at 14 weeks or 6 months post
delivery (Table 4). Sub-group analysis within each BMI
category viz. ≤ 24.9 kg/m
2 and ≥ 25 kg/m
2 revealed no
significant differences in the changes of the measure-
ments except for LBM (Table 5). LBM decreased in
both groups of subjects with low BMI, however there
HIV Positive Mothers 
at ANC
Voluntarily chosen 
Breastfeeding N=129
Feed Counselling
Household supplies 
N=63
Nutritional supplement
N=66
Randomisation
N=60; 3 LTF N=57; 9 LTF
N=58; 2 LTF N=56; 1 D
N=52; 2 D,4 LTF N=55; 1 D
14 weeks
6 months
9 months
N= Number of mother-baby pairs
D=child deaths
LTF-lost to follow-up
Figure 1 Study design and flow diagram of follow-up.
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Page 5 of 12Table 2 Socio-demographic and laboratory parameters of the mothers at baseline
Variables Breastfeeding: control (n
= 63)
Breastfeeding: supplemented
(n = 66)
p value for the difference
between groups
Age years Mean (SD) 24.9 (4.21) 25.85 (4.85) 0.241
Marital status:
Single/cohabiting (% within group)
59 (93.7) 65 (98.5) 0.155
Access to water
(% within group)
Own tap 36 (57.1) 32 (48.5) 0.327
Public tap 26 (41.3) 34 (51.5)
Other 1(1.6) 0 (0)
Access to Electricity (% within
group)
38 (60.3) 30 (45.5) 0.091
Access to
Sanitation (% within group)
Waterborne 29 (46) 28 (42.4) 0.522
Pit 33 (52.4) 38(57.6)
Nil 1 (1.6) 0 (0)
Source of income
(%within group)
Self 12 (19) 16 (24.2) 0.286
Partner 25 (39.7) 23 (34.8)
Family 21 (33.3) 26 (39.4)
Grants 5 (7.9) 1 (1.5)
Food insecurity (% within group) 20 (31.7) 21 (31.8) 0.993
Disclosure to family (% within group) 29 (46) 27 (40.9) 0.557
Disclosure to partner (%within group) 38 (60.3) 40 (60.6) 0.973
Contraception use (% within group) 48 (76.2) 46 (69.7) 0.407
Median years of schooling (IQR) 11 (10-12) 11 (10-12) 0.515
Median size of household (IQR) 3 (2-5) 3 (2-5) 0.901
Median parity (IQR) 2 (1-3) 2 (1-3) 0.829
Past history of TB (% within group) 1 (1.6) 3 (4.5) 0.375
Past history of STI (% within group) 10 (15.9) 10 (15.2) 0.583
BMI kg/m
2 Median (IQR) 26.53 (23.37-30.1) 26.18 (23-30.67) 0.793
CD4 cells/μL Median(IQR) 413 (312-492) 443.5 (294.8-564) 0.658
Haemoglobin g/dL Mean (SD) 11.84 (1.59) 11.47 (1.52) 0.183
Total Protein g/L Mean (SD) 79.12 (7.12) 79.45 (8.22) 0.808
Albumin g/L Mean (SD) 32.27 (4.21) 30.86 (4.85) 0.065
Table 3 Baseline anthropometric measurements amongst the two groups of infants at 2 weeks of age
Breastfeeding control (n =
63)
Breastfeeding supplemented (n =
66)
P value (95% CI of the
difference)
Weight kg Mean (SD) 3.72 (0.58) 3.66 (0.48) 0.538 (-0.13, 0.24)
Length cm Mean (SD) 50.89 (2.42) 51.02 (1.98) 0.734 (-0.90, 0.64)
HC cm Mean (SD) 36.2 (1.43) 36.45 (1.19) 0.282 (-0.71, 0.21)
MUAC cm Mean (SD) 10.73 (0.98) 10.56 (0.93) 0.317 (-0.16, 0.50)
TSF mm Mean (SD) 6.67 (1.35) 6.29 (1.50) 0.135 (-0.12, 0.88)
BMI kg/m
2 Mean (SD) 14.27 (1.49) 14.03 (1.35) 0.335 (-0.25, 0.74)
Weight/Age z scores Mean (SD) -0.14 (1.05) -0.21 (0.89) 0.672 (-0.26, 0.41)
Length/Age z score Mean (SD) -0.72 (1.12) -0.63 (1.02) 0.650 (-0.46, 0.29)
HC/Age z score Mean (SD) 0.37 (1.06) 0.60 (1) 0.210 (-0.59, 0.13)
BMI/Age z score Mean (SD) 0.37 (1.09) 0.2 (1) 0.360 (-0.19, 0.53)
Weight/Length z score Mean
(SD)
0.46 (1.07) 0.2 (1.13) 0.194 (-0.13, 0.64)
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supplemented group (1.32 kg) when compared to the
control group (3.17 kg); p = 0.026. However, in the sub-
jects with high BMI, there were no significant differ-
ences between the groups. Further analysis using GEE
adjusted for baseline age, CD4 and duration of breast-
feeding was conducted. Data were analysed separately
for mothers with BMI ≤ 24.9 kg/m
2 and ≥ 25 kg/m
2.I n
the mothers with BMI ≥ 25 kg/m
2, no effect of supple-
mentation on any of the measurements was seen. In
mothers with BMI ≤ 24.9 kg/m
2; no significant effect of
the supplementation was seen except in LBM where the
supplemented group had a significantly lower loss in
LBM (0.098 kg) compared to the control group.
There were no significant differences between the
changes for all the laboratory parameters viz. CD4
count, haematology and albumin in both groups
between 2 weeks and 6 months. The sub-group analyses
within BMI categories ≤ 24.9 kg/m
2 and ≥ 25 kg/m
2
also showed no statistically significant differences.
There were no significant differences in the crude
incidence rates or IRR of opportunistic infections such
as LRTI, diarrhea, candidiasis, TB as well as the depres-
sion and Karnofsky scores between the two groups of
mothers. This was confirmed on further analysis using
GLM adjusting for CD4, age and duration of
breastfeeding.
On assessing the effect of maternal supplementation on
infant growth cross-sectionally, the MUAC, TSF, BMI
measurements as well as the mean z scores for weight/
age, weight/length, MUAC/age and TSF/age were signifi-
cantly higher in the control group compared to the sup-
plemented group at 14 weeks (Table 6). However,
analysing infant growth longitudinally using GEE
adjusted for mother’s CD4 count, BMI and duration of
breastfeeding these differences were no longer significant.
Table 4 Effect of nutritional supplementation on Body composition and anthropometric measures of breastfeeding
mothers from 2 weeks to 6 months
Mean change in variable over 6
months (SD)
Breastfeeding
Control (n = 57)
Breastfeeding
Supplemented (n = 56)
P value for the difference between the groups (95%
CI for the difference)
Weight in kg -0.43 (4.78) -1.61 (4.89) 0.196 (-0.62, 2.97)
BMI in kg/m
2 -0.13 (1.94) -0.64 (1.97) 0.164 (-0.21, 1.24)
MUAC in cm 1.20 (1.62) -0.90 (1.73) 0.349 (-0.33, 0.92)
TSF in mm 4.14 (4.69) 2.87 (4.88) 0.161 (-0.51, 3.05)
LBM in kg -3.78 (4.1) -3.20 (3.52) 0.569 (-2.59, 1.44)
Fat mass in kg 4.14 (4.57) 3.21 (5.77) 0.490 (-1.76, 3.63)
%Fat mass 6.07 (5.46) 4.5 (6.53) 0.316 (-1.55, 4.70)
Table 5 Sub-group analysis of the effect of nutritional supplementation on Body composition and anthropometric
measures of breastfeeding mothers (by BMI category)
Change in
variable over 6
months
Low to normal BMI (≤ 24.99 kg/m
2) High BMI (≥ 25 kg/m
2)
Breastfeeding
Control (n =
22)
Breastfeeding
Supplemented
(n = 27)
P value for the
difference between the
groups (95% CI)
Breastfeeding
Control (n =
35)
Breastfeeding
Supplemented
(n = 30)
p value for the
difference between the
groups (95% CI)
Wt kg Mean
(SD)
0.3 (4.45) -0.94 (3.9) 0.306 (-1.17, 3.64) -0.89 (4.99) -2.22(5.63) 0.318 (-1.31, 3.96)
BMI kg/m
2
Mean (SD)
0.23 (1.76) -0.36 (1.51) 0.215 (-0.35, 1.53) -0.36 (2.04) -0.90 (2.31) 0.316 (-0.53, 1.62)
MUAC cm
Mean (SD)
1.44(1.61) 0.69(1.35) 0.083 (-0.10, 1.60) 1.05 (1.64) 1.10 (2.03) 0.910 (- 0.97, 0.86)
TSF mm Mean
(SD)
4.45(4.15) 3.11(4.53) 0.291 (-1.18, 3.86) 3.95(5.04) 2.65(5.26) 0.318 (-1.28, 3.88)
LBM kg
Mean (SD)
-3.71 (2.76) -1.32(2.46) 0.026 (-4.46,-0.32) -3.84(5.2) -4.71(3.57) 0.597 (-2.44, 4.16)
FM kg
Mean (SD)
4.58 (3.86) 1.72(4.7) 0.090 (-0.47, 6.18) 3.71(5.28) 4.4 (6.4) 0.747 (-4.98, 3.62)
%FM
Mean (SD)
7.17(4.87) 2.55(5.82) 0.031
(0.46, 8.77)
4.98 (5.93) 6.05 (6.84) 0.643 (-5.77, 3.62)
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and development scores amongst the infants, no signifi-
cant differences were seen between the two groups.
There were four infant deaths (3.1%). All were HIV
positive and the deaths were attributed to gastroenteritis
related morbidity. All HIV positive infants were started
on ART.
Discussion
There were no significant differences between the two
groups at baseline in terms of socio-demographic vari-
ables and laboratory parameters. Statistically there was a
difference in breastfeeding duration between the groups
with the control group breastfeeding for a median of 6
months compared to 5.5 months in the intervention
Table 6 Effect of maternal supplementation on growth of the breastfed infant
Growth and development
parameters
Breastfeeding
control
(n = 63)
Breastfeeding
supplemented
(n = 66)
p value for the difference
between the groups (95% CI of
the difference)
*Adjusted p value for the difference
between the groups (95% CI of the
difference)
Weight/age z
scores Mean (SD)
14
weeks
0.44 (1.03) 0.06 (1.09) 0.058 (-0.01, 0.77) 0.455 (-1.52, 0.68)
6
months
0.61 (1.17) 0.15 (1.13) 0.035 (0.03, 0.88)
9
months
0.65 (1.16) 0.28 (1.15) 0.098 (-0.07, 0.82)
Length/age z score
Mean (SD)
14
weeks
-0.59 (1.08) -0.48 (1.12) 0.613 (-0.51, 0.3) 0.891 (-1.29. 1.12)
6
months
-0.35 (1.03) -0.47 (1.24) 0.574 (-0.3, 0.54)
9
months
0.39 (1.14) 0.41 (1.17) 0.899 (-0.42, 0.47)
Head
circumference/age z
score Mean (SD)
14
weeks
0.50 (1.07) 0.73 (1.1) 0.249 (-0.63, 0.17) 0.247 (-1.45, 0.37)
6
months
0.42 (1.19) 0.66 (1.03) 0.267 (-0.64, 0.18)
9
months
0.51 (1.02) 0.68 (1.01) 0.368 (-0.57, 0.21)
BMI/age z score
Mean (SD)
14
weeks
1.06 (0.98) 0.46 (1.11) 0.058 (-0.01, 0.77) 0.154 (-1.29, 0.21)
6
months
1.07 (1.14) 0.56 (1.2) 0.021 (0.08, 0.94)
9
months
1.17 (1.17) 0.69 (1.23) 0.042 (0.02, 0.94)
Weight/length z
score Mean (SD)
14
Weeks
1.26 (0.96) 0.64 (1.1) 0.002 (0.23, 0.99) 0.154 (-1.08, 0.17)
6
months
1.15 (1.11) 0.67 (1.16) 0.026 (0.06, 0.9)
9
months
1.18 (1.14) 0.72 (1.19) 0.041 (0.02, 0.92)
MUAC/age z score
Mean (SD)
14
weeks
0.49 (0.97) 0.04 (1.08) 0.02 (0.07, 0.83) 0.145 (-4.78, 0.71)
6
months
0.62 (1.07) 0.25 (1.17) 0.076 (-0.04, 0.79)
9
months
0.79 (1.05) 0.38 (1.05) 0.046 (0.01, 0.82)
TSF/age z score
Mean (SD)
14
weeks
0.64 (0.77) 0.06 (1.08) 0.001 (0.24, 0.93) 0.178 (-4.33, 0.8)
6
months
0.95 (0.48-1.6) 0.52 (-0.09-1.23) 0.013
9
months
1.32 (0.47-1.75) 0.74 (-0.07-1.3) 0.004
*Adjusted for maternal CD4 count and BMI at baseline and duration of breastfeeding
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Page 8 of 12group, however “clinically” this difference is not really
meaningful. Nevertheless we did control for breastfeed-
ing duration in our analyses. Unexpectedly we found
that not all the mothers consumed the supplement
appropriately (taking the prescribed amount daily). It
had been assumed that the supplement was acceptable
in our community as the provincial heath department
was using it in hospitals and clinics. However on asking
mothers why they did not take the supplement appro-
priately we discovered that 39.4% of the mothers
reported that the supplement was too sweet. This,
together with the fact that not all mothers breastfed for
the full 6 months was an obvious limitation of the study
as the hypothesis of the study was that approximately 6
months of supplement would have an impact on the
body composition of the mothers. Nutritional supple-
ments in the context of HIV in South Africa are often
viewed suspiciously by the population as they view car-
rying parcels home could direct attention towards them
as HIV is still associated with stigma. This was reported
by Doherty et al. when they assessed the acceptability of
the free formula being provided nationally in South
Africa [40]. However other studies, one in an HIV
infected population and another where the HIV status
was unknown found supplements to be acceptable
[41,42]. A Mexican study found the acceptability of sup-
plements to be poor due to the taste, the women pre-
ferred the tablets [43]. They also advise the use of
locally available nutritious foods which would be cultu-
rally acceptable.
Davies et al. successfully showed in their “breaking the
cycle project” that by training peers from a targeted
community in nutrition education as well as in using
culturally acceptable recipes helped them to engage with
the community [44]. This led to a significant change in
dietary habits. The importance of including a “holistic
food based approach” using nutritionally valuable tradi-
tional food, which can be grown easily, be sustainable
and more empowering is supported by the findings of
our study [45].
When considered as a whole the two groups were
similar in terms of changes in anthropometric mea-
surements and body composition changes. We investi-
gated the effect of supplementation as per BMI
category to assess if the mothers on whom lactation
would be an extra metabolic demand i.e. the mothers
with a low BMI were not being more compromised. It
was noted that the supplemented mothers with a low
BMI actually lost a significantly lower amount of LBM
compared to the control mothers (1.32 kg vs. 3.17 kg;
p = 0.026). Even when controlling for baseline age,
CD4 and duration of breastfeeding, this effect
remained. The nutritional supplement to the group of
lactating mothers with low BMI was therefore effective
in preventing some loss of LBM presumably by provid-
ing additional protein to compensate for low dietary
protein intake. This has been the first published study
assessing the impact of nutritional supplementation on
c h a n g e si nL B Mo fH I Vp o s i t i v eb r e a s t f e e d i n g
mothers. Prentice et al. observed increased subcuta-
neous fat and increased weights in their study of nutri-
tional supplementation of non-HIV infected
breastfeeding mothers; however no body composition
measurements were done [46].
The nutritional supplement had no impact on any of
the laboratory parameters assessed. This however was
also observed in a Cochrane review of nutritional inter-
ventions in HIV infected men and non-postpartum
women [47]. There were no differences between the
groups for incidence rates of any of the opportunistic
infections.
In view of the mean BMI being high, all mothers
should be encouraged to exercise in the post-natal per-
iod as it has been shown to increase lean body mass as
well as improve cardio-respiratory fitness [48]; this is
especially important as HIV has been shown to be inde-
pendently associated with cardiovascular disease and
metabolic disorders [49].
On comparing infant growth, the control group
appeared to have significantly higher mean MUAC, TSF
and BMI measurements. However, on further assess-
ment controlling for important confounders’ viz. base-
line maternal CD4 count, BMI and duration of
breastfeeding these were no longer significant. Further-
more nutritional supplementation to the mothers had
no impact on infections in their infants.
Four of the infants died; all of whom were HIV
infected. The deaths were all secondary to gastroenteri-
tis; and occurred within a few months of breastfeeding
cessation (three stopped before 3 months and one at 6
months). Therefore our findings endorse the importance
of the revised WHO recommendations which encourage
breastfeeding for 12 months (in the presence of ARV
prophylaxis) because they have taken into account not
only HIV infection but also child survival [13].
Study limitations
The study was powered to detect a 4 kg difference in
lean body mass between the supplemented and non-
supplemented groups. Altho u g ht h i sm a yh a v eb e e na
bit too ambitious we particularly chose this effect as we
wanted to see a more definitive impact because of the
huge cost implications if such an intervention was to be
instituted as a policy following this study. This study
was therefore limited in that it obviously did not have
sufficient power to detect a a smaller difference in lean
body mass as well as any effect on CD4 counts and
other parameters.
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expected adherence to the supplement have already
been discussed; nevertheless the study was planned as
an “intention-to-treat” study. A further limitation of the
study could be that the supplementation was not given
as a meal replacement but as a supplement at a dose of
50 g/day; which only covered a fraction of the macronu-
trient requirements. We did however compare the diet-
ary intake of the two groups of breastfeeding mothers
which we found to be similar therefore the impact of
the supplement was not influenced by background diet-
ery intake.
Further, we had not determined the categorisation of
BMI at the onset of the study, although WHO defini-
tions were used to determine the cutoff.
Conclusions
Nutritional supplementation had no impact on the
group of mothers as a whole except for the small group
of mothers with low BMI. There is however a possibility
that if a larger daily dose of the supplement was used
instead of 50 g daily, an impact of the intervention on
prognostic indicators may have been seen. We would
therefore recommend that nutritional supplements
should only be provided in a well thought-out targeted
approach.
Supplement interventions often do not make an
impact due to nonadherence. Nonadherence can be due
to exchanging, selling and sharing the supplement or
even discarding it if associated by the subject with any
socially stigmatizing disease. Therefore programmes
using supplement interventions should take the time to
do preliminary work on acceptability of the proposed
intervention.
Although there is a place for food parcels in emer-
gency situation such as environmental crises, civil wars
etc., their use in routine practice especially in today’s
environment of global economic instability is not sus-
tainable and is disempowering. There is a need to put
people in control of their own health. One of the solu-
tions could be to include simple and easy to follow
nutrition guidelines during health education in primary
health care clinics and antenatal clinics.
Future research priorities should include studying the
impact of using locally available and thus sustainable
nutrient rich foods on breastfeeding mothers with a low
BMI as well as the effect of nutrition education during
the antenatal as well as in the well-baby clinic follow-up
period which would help both mothers with a low and
high BMI.
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